Concerns about new variants and low vaccination rates are fueling many immunocompromised adults to receive the extra doses, despite uncertainty about their safety and effectiveness, the Times said.
The CDC updated its vaccination guidelines in October, saying immunocompromised people are eligible for a fourth vaccine dose six months after their third. For those who followed federal guidelines, the earliest eligibility for a fourth dose would be in late February.
Israel became the first country to broadly roll out fourth doses Jan. 2, amid the omicron surge. The country is permitting healthcare workers and residents aged 60 and older to get an extra dose, according to the Times.
View the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
